Journal Article
Validation Study
Add like
Add dislike
Add to saved papers

Staging of keratoconus indices regarding tomography, topography, and biomechanical measurements.

PURPOSE: To derive limits of metric keratoconus indices for classification into keratoconus stages.

DESIGN: Validity and reliability analysis of diagnostic tools.

METHODS: A total of 126 patients from the keratoconus center of Homburg/Saar were evaluated with respect to Amsler criteria, using Pentacam (Keratoconus Index [KI], Topographic Keratoconus Classification [TKC]), Topographic Modeling System (Smolek/Klyce, Klyce/Maeda), and Ocular Response Analyzer (Keratoconus Match Probability [KMP], Keratoconus Match Index [KMI]). Mean value, standard deviation, 90% confidence interval, and the Youden J index for definition of the thresholds were evaluated.

RESULTS: For separation of keratoconus stages 0/1/2/3/4 we derived the following optimum thresholds: for KI 1.05/1.15/1.31/1.49 and for KMI 0.77/0.32/-0.08/-0.3. For Smolek/Klyce and Klyce/Maeda high standard deviations and overlapping confidence intervals were found; therefore no discrete thresholds could be defined. Nevertheless, for them we still found a good sensitivity and specificity in discriminating between healthy (stage 0) and keratoconus (stages 2-4) eyes in comparison with the other indices.

CONCLUSIONS: We derived thresholds for the metric keratoconus indices KI and KMI, which allow classification of keratoconus stages. These now need to be validated in clinical use. Smolek/Klyce and Klyce/Maeda were not sufficiently sensitive to allow classification into individual stages, but these indices did show a good specificity and sensitivity in discriminating between keratoconus and healthy eyes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app